Log in

ASTALLTD Astal Laboratories Ltd BSE · India

Astal Laboratories (ASTALLTD) news

Astal Laboratories Ltd is a public biotech or pharmaceutical company listed on BSE under the ticker ASTALLTD, recorded under India. The directory classifies it as Drug manufacturing / APIs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Astal Laboratories news

We have not published a story on Astal Laboratories yet. When there is news, it will appear here.

Questions about Astal Laboratories

What is the ticker symbol of Astal Laboratories?

Astal Laboratories Ltd trades under the ticker ASTALLTD on BSE.

Where is Astal Laboratories listed?

Astal Laboratories Ltd is listed on BSE.

Which country or territory is Astal Laboratories listed under?

Our directory records Astal Laboratories Ltd under India.

What does Astal Laboratories do?

Our directory classifies Astal Laboratories Ltd as: Drug manufacturing / APIs. This is a directory classification, not a description of the pipeline.

What is the ISIN of Astal Laboratories?

The ISIN recorded for Astal Laboratories Ltd is INE307N01014.

Does aibio.space cover Astal Laboratories?

aibio.space lists Astal Laboratories Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Astal Laboratories?

Companies in our directory listed in the same country and business area as Astal Laboratories: Everest Organics, Concord Biotech, Asston Pharmaceuticals, IOL Chemicals & Pharmaceuticals, Par Drugs and Chemicals, Solara Active Pharma Sciences.

Investor discussion: Astal Laboratories

Members talk about Astal Laboratories (ASTALLTD). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BSE:ASTALLTD on TradingView.

Listing details

Astal Laboratories Ltd is a public biotech or pharmaceutical company listed on BSE under the ticker ASTALLTD, recorded under India. The directory classifies it as Drug manufacturing / APIs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Astal Laboratories Ltd
Ticker
ASTALLTD
Listing
BSE
Country or territory
India
Business scope
Drug manufacturing / APIs
ISIN
INE307N01014
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.